SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiao Qu, Zhaofei Pang, Weiwei Yi, Ying Wang, Kai Wang, Qi Liu, Jiajun Du, High percentage of α1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer, Medical Oncology, 2014, 31, 10

    CrossRef

  2. 2
    Erin L. Skornicka, Nadya Kiyatkina, Matthew C. Weber, Mark L. Tykocinski, Peter H. Koo, Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production, Cellular Immunology, 2004, 232, 1-2, 144

    CrossRef

  3. 3
    Hiroaki Kataoka, Hiroshi Itoh, Masashi Koono, Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration, Pathology International, 2002, 52, 2
  4. 4
    Hiroaki Kataoka, Hirofumi Uchino, Takeshi Iwamura, Motoharu Seiki, Kazuki Nabeshima, Masashi Koono, Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of α1-Proteinase Inhibitor Generated by Matrix Metalloproteinases, The American Journal of Pathology, 1999, 154, 2, 457

    CrossRef

  5. 5
    Hugo R. Rosen, LIVER DISEASE ASSOCIATED WITH ALPHA1-ANTITRYPSIN DEFICIENCY, Clinics in Liver Disease, 1998, 2, 1, 175

    CrossRef

  6. 6
    Abdul-Nasser Elzouki, Hans Verbaan, Stefan Lindgren, Anders Widell, Joyce Carlson, Sten Eriksson, Serine protease inhibitors in patients with chronic viral hepatitis, Journal of Hepatology, 1997, 27, 1, 42

    CrossRef

  7. 7
    Michael G. Brown, Anthony A. Scalzo, Keiko Matsumoto, Wayne M. Yokoyama, The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity, Immunological Reviews, 1997, 155, 1
  8. 8
    Andrzej Mackiewicz, 1997,

    CrossRef

  9. 9
    Joakim Göransson, Svante Jonsson, ke Lasson, Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery, European Journal of Surgical Oncology (EJSO), 1996, 22, 6, 607

    CrossRef

  10. 10
    Theresa Propst, Albert Propst, Otto Dietze, Gert Judmaier, Herbert Braunsteiner, Wolfgang Vogel, Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency, Journal of Hepatology, 1994, 21, 6, 1006

    CrossRef

  11. 11
    C.D. Richards, J. Gauldie, Xenobiotics and Inflammation, 1994,

    CrossRef

  12. 12
    A. Montanelli, D. Barberis, C. Montanini, E. Costa, Alpha-1 -Antitrypsin Deficiency and Viral Infections, Vox Sanguinis, 1993, 65, 4
  13. You have free access to this content13
    M. S. BASHIR, D. B. JONES, D. H. WRIGHT, Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells, Clinical & Experimental Immunology, 1992, 88, 3
  14. 14
    P. D. Sibraa, R. A. Reinhardt, J. K. Dyer, L. M. DuBois, Acute-phase protein detection and quantification in gingival crevicular fluid by direct and indirect immunodot, Journal of Clinical Periodontology, 1991, 18, 2
  15. 15
    David A. Johnson, Mark W. Frampton, R. Steve Winters, Paul E. Morrow, Mark J. Utell, Inhalation of Nitrogen Dioxide Fails to Reduce the Activity of Human Lung Alpha-1-Proteinase Inhibitor, American Review of Respiratory Disease, 1990, 142, 4, 758

    CrossRef

  16. 16
    R.E. Banks, S.W. Evans, F. Van Leuven, D. Alexander, M.J. McMahon, J.T. Whicher, Measurement of the ‘fast’ or complexed form of α2 macroglobulin in biological fluids using a sandwich enzyme immunoassay, Journal of Immunological Methods, 1990, 126, 1, 13

    CrossRef

  17. 17
    Seiichiro Karashima, Hiroaki Kataoka, Hiroshi Itoh, Riruke Maruyama, Masashi Koono, Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas, International Journal of Cancer, 1990, 45, 2
  18. 18
    Inger Edfors-Lilja, R. K. Juneja, B. Gahne, Association between plasma protease inhibitor haplotypes and IgG response to E. coli antigens in pigs, Journal of Animal Breeding and Genetics, 1989, 106, 1-6
  19. 19
    Mark W. Frampton, Jacob N. Finkelstein, Norbert J. Roberts, Anthony M. Smeglin, Paul E. Morrow, Mark J. Utell, Effects of Nitrogen Dioxide Exposure on Bronchoalveolar Lavage Proteins in Humans, American Journal of Respiratory Cell and Molecular Biology, 1989, 1, 6, 499

    CrossRef

  20. 20
    Hiroaki Kataoka, Kazuki Nabeshima, Naoto Komada, Masashi Koono, New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro, Virchows Archiv B Cell Pathology Including Molecular Pathology, 1989, 57, 1, 157

    CrossRef

  21. 21
    HOWARD K. GERSHENFELD, R. JANE HERSHBERGER, CHRISTOPH MUELLER, IRVING L. WEISSMAN, A T Cell- and Natural Killer Cell-Specific, Trypsin-like Serine Protease, Annals of the New York Academy of Sciences, 1988, 532, 1
  22. 22
    R. Meliconi, O. Parracino, A. Facchini, A. M. Morselli-Labate, Flavia Bortolotti, F. Tremolada, M. Martuzzi, F. Miglio, G. Gasbarrini, Acute phase proteins in chronic and malignant liver diseases, Liver, 1988, 8, 2
  23. 23
    Raymond Sawaya, Mario Zuccarello, Robert Highsmith, Alpha-1-antitrypsin in human brain tumors, Journal of Neurosurgery, 1987, 67, 2, 258

    CrossRef

  24. 24
    H.P. Godfrey, Ursula Malorny, E. Michels, Gail S. Habicht, A. Atlas, B. Randazzo, C. Sorg, Murine Alpha-2-Macroglobulin: Localization on a Subpopulation of Macrophages, Immunobiology, 1987, 175, 3, 183

    CrossRef

  25. 25
    Richard H. Seder, Charles W. Vaughan, Se-Kyung Oh, John J. Keggins, John A. Hayes, Gordon C. Blanchard, Miriam E. Vincent, Arnold E. Katz, Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancer, Cancer, 1987, 60, 3
  26. 26
    Lars Sottrup-Jensen, The Plasma Proteins, 1987,

    CrossRef

  27. 27
    Vladimír Bencko, Vladimír Wagner, Maria Wagnerova, Vladimír Zavázal, Human exposure to nickel and cobalt: Biological monitoring and immunobiochemical response, Environmental Research, 1986, 40, 2, 399

    CrossRef

  28. 28
    M.B. Kahaleh, F. DeLustro, William Bock, E.Carwile LeRoy, Human monocyte modulation of endothelial cells and fibroblast growth: Possible mechanism for fibrosis, Clinical Immunology and Immunopathology, 1986, 39, 2, 242

    CrossRef

  29. 29
    Leena Sandholm, Proteases and their inhibitors in chronic inflammatory periodontal disease, Journal of Clinical Periodontology, 1986, 13, 1
  30. 30
    John Ding-E Young, Zanvil A. Cohn, Role of granule proteins in lymphocyte-mediated killing, Journal of Cellular Biochemistry, 1986, 32, 2
  31. 31
    J.H. Wyckoff, B.T. Shannon, M. Petrini, E. Merler, Acquired Spontaneous Cytotoxicity of K562 in a Subpopulation of Monocytes, Immunobiology, 1985, 169, 2, 175

    CrossRef

  32. 32
    Gerald Shulman, James O. Ballard, M. Elaine Eyster, Changes in plasma haptoglobin and alpha-2-macroglobulin in hemophiliacs receiving factor replacement therapy, American Journal of Hematology, 1985, 18, 3
  33. 33
    Anne M. Dickinson, B.K. Shenton, A.H. Alomran, P.K. Donnelly, S.J. Proctor, Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor α2-macroglobulin (α2M) and α2M protease complexes, Clinical Immunology and Immunopathology, 1985, 36, 3, 259

    CrossRef

  34. 34
    Samuel N. Breit, Denis Wakefield, J.Paul Robinson, Elizabeth Luckhurst, Peggy Clark, Ronald Penny, The role of α1-antitrypsin deficiency in the pathogenesis of immune disorders, Clinical Immunology and Immunopathology, 1985, 35, 3, 363

    CrossRef

  35. 35
    Ronald H. Goldfarb, Mechanisms of Cytotoxicity by NK Cells, 1985,

    CrossRef

  36. 36
    J. J. LI, M. E. A. PEREIRA, R. A. DELELLIS, K. P. W. J. McADAM, Human Amyloid P Component: A Circulating Lectin that Modulates Immunological Responses, Scandinavian Journal of Immunology, 1984, 19, 3
  37. 37
    WANDA ZBROJA-SONTAG, Cell-Mediated Immunity in the Blood of Women With Inflammatory and Neoplastic Lesions of the Ovary, American Journal of Reproductive Immunology, 1983, 4, 3
  38. 38
    M. R. Laurent, K. I. Welsh, GENETIC MARKERS IN RHEUMATOLOGICAL DISEASES, International Journal of Immunogenetics, 1983, 10, 4
  39. 39
    Thomas Henriksson, Inhibition of natural killing by adenosine ribonucleotides, Immunology Letters, 1983, 7, 3, 171

    CrossRef

  40. 40
    Ian Kimber, Michael Moore, Kevan Roberts, Variance in resistance to natural and antibody-dependent cellular cytotoxicity and to complement-mediated lysis among K562 lines, International Journal of Cancer, 1983, 32, 2
  41. 41
    P. GRAVAGNA, E. GIANAZZA, P. ARNAUD, M. NEELS, E. W. ADES, Modulation of the Immune Response by Plasma Protease Inhibitors, Scandinavian Journal of Immunology, 1982, 15, 1